After Bell Investing

Simulation · C1–C8 · 2026 · free curves

2026 from the 2026-01-01 close

Each C book starts with $10,000 at the first session on or after 1 January 2026 and marks every session after it. The solid ink line is the book we trade. The dotted slate line is the same book with E2 (vol dial σ*=28% — cut exposure when the book’s recent volatility is high). Copper is the benchmark. The dashed line is the same stake left in cash (cash earns nothing). Curves are public. The names and entry dates stay behind site membership — that is the sell. Research paper, not a broker, not advice.

Subscribe to the site to see which names each book holds and when it bought them. One membership opens every C book — there is no per-strategy checkout.

C1 · Watchlist

vs cash 34,069 · +340.7%

$10,000 at the 2026-01-02 close, marked through 2026-10-23. The pair steps aside while SPY is under its 200-session average. Cash left untouched earns nothing.

$48,130$10,0002026-01-022026-10-23

E2 scales this book toward σ*=28% (21-session vol, 21-session review, 5% band). Risk control on the same path — not a new strategy.

2026-01-02 through 2026-10-23. 19 changes. 10 bps on each buy and each sale. Cash earns nothing. Names and entry dates stay behind site membership. Research, not an order.

C2 · Nasdaq, no average

No tape yet

The Nasdaq-100 half-year pair, held through every session. No 200-session cash rule. Included with site membership.

Waiting on the daily Simulation file for C2 · Nasdaq, no average (from 2026-01-01). Research, not an order.

C3 · Nasdaq + sleeve

No tape yet

The Nasdaq-100 half-year two, plus at most one stock from a separate sleeve of names outside the S&P 500 and the Nasdaq-100. Cash the session after QQQ closes under its own 200-session average. Included with site membership.

Waiting on the daily Simulation file for C3 · Nasdaq + sleeve (from 2026-01-01). Research, not an order.

C4 · Nasdaq with average

No tape yet

The two strongest names on the Nasdaq-100 over about six months. Cash the session after QQQ closes under its own 200-session average. Included with site membership.

Waiting on the daily Simulation file for C4 · Nasdaq with average (from 2026-01-01). Research, not an order.

C5 · S&P 500 + SPY 200-day

No tape yet

The two strongest names in the S&P 500 over about six months. Cash the session after SPY closes under its 200-session average. Included with site membership.

Waiting on the daily Simulation file for C5 · S&P 500 + SPY 200-day (from 2026-01-01). Research, not an order.

C6

vs cash 2,481 · +24.8%

$10,000 at the 2026-03-27 close, marked through 2026-10-23. The book is either invested or cash. Cash left untouched earns nothing.

$14,676$10,0002026-03-272026-10-23

E2 scales this book toward σ*=28% (21-session vol, 21-session review, 5% band). Risk control on the same path — not a new strategy.

2026-03-27 through 2026-10-23. 1 change. 10 bps on each buy and each sale. Cash earns nothing. Names and entry dates stay behind site membership. Research, not an order.

C7 · Sector pair names

vs cash 11,571 · +115.7%

$10,000 at the 2026-01-02 close, marked through 2026-10-23. Every 126 sessions the book equal-weights the strongest research_wide name in each of the two strongest GICS sector ETFs by 12−1. Cash left untouched earns nothing.

$25,516$10,0002026-01-022026-10-23

E2 scales this book toward σ*=28% (21-session vol, 21-session review, 5% band). Risk control on the same path — not a new strategy.

2026-01-02 through 2026-10-23. 16 changes. 10 bps on each buy and each sale. Cash earns nothing. Names and entry dates stay behind site membership. Research, not an order.

C8 · Half-year sector pair

vs cash 2,380 · +23.8%

$10,000 at the 2026-01-02 close, marked through 2026-10-23. On each month-end the book equal-weights the strongest equity in each of the two strongest GICS sector ETFs by half-year strength (SSGA holdings when snapshotted; otherwise mapped research_wide names). Cash left untouched earns nothing.

$13,085$10,000$9,2512026-01-022026-10-23

E2 scales this book toward σ*=28% (21-session vol, 21-session review, 5% band). Risk control on the same path — not a new strategy.

2026-01-02 through 2026-10-23. 89 changes. 10 bps on each buy and each sale. Cash earns nothing. Names and entry dates stay behind site membership. Research, not an order.